e-learning
resources
Munich 2006
Sunday 03.09.2006
Lung cancer, haemoptoe, smoking and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Shall we disclose the diagnosis of lung cancer to the patient?
N. Ucar, F. Yardim, O. Orsel, S. Alpar, S. F. Guven, B. Kurt (Ankara, Bolu, Turkey)
Source:
Annual Congress 2006 - Lung cancer, haemoptoe, smoking and COPD
Session:
Lung cancer, haemoptoe, smoking and COPD
Session type:
E-Posters in free access
Number:
344
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Ucar, F. Yardim, O. Orsel, S. Alpar, S. F. Guven, B. Kurt (Ankara, Bolu, Turkey). Shall we disclose the diagnosis of lung cancer to the patient?. Eur Respir J 2006; 28: Suppl. 50, 344
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pulmonary function in elderly patients with diagnosis of lung cancer – an excuse for giving up surgery?
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008
Patient and doctor delay in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006
How do lung cancer patients die?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Truth telling to lung cancer diagnosed patients and expectations for taking responsibility at treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 229s
Year: 2004
Poor performance status patient in advanced lung cancer: to treat or not to treat?
Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat?
Year: 2008
Detection of operable lung cancer – a question of sheer luck?
Source: Eur Respir J 2007; 30: Suppl. 51, 563s
Year: 2007
Quality of life in lung cancer: does disclosing of the diagnosis have an impact?
Source: Annual Congress 2003 - Lung cancer management and prognosis
Year: 2003
Management of incidental nodules in lung cancer screening: ready for prime-time?
Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019
Year: 2019
Granulomatous reaction in a patient with lung cancer: should we treat it?
Source: Breathe, 14 (3) e94; 10.1183/20734735.014617
Year: 2018
Breath biomarkers for lung cancer detection: ready for use by the pulmonologist?
Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer
Year: 2012
Non-small cell lung cancer: how do experts want to be treated?
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Treatment of early lung disease – is it possible? Does it work?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004
Who should treat lung cancer patients and where should they be treated?
Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients
Year: 2009
Diagnosing lung cancer: is the 28 day rule appropriate?
Source: Eur Respir J 2004; 24: Suppl. 48, 298s
Year: 2004
Patients referred to a lung cancer clinic – does a clinical assessment at the outset have an impact on the investigations requested?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
What’s new in interstitial lung diseases in children?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021
Lung cancer: clinical presentation and specialist referral time
Source: Eur Respir J 2004; 24: 898-904
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept